Clinical trials
Observational Asthma trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 10 |
| 2022 | 6 |
| 2023 | 9 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Unknown status | 15 |
| Terminated | 7 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 15 |
| University Hospital, Montpellier | 11 |
| University Hospital, Lille | 6 |
| AstraZeneca | 5 |
| Hospices Civils de Lyon | 5 |
| Sanofi | 4 |
| University Hospital, Bordeaux | 4 |
| University Hospital, Toulouse | 3 |
| CHU de Reims | 2 |
| Central Hospital, Nancy, France | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 82 |
| Pulmonary Disease, Chronic Obstructive | 9 |
| Bronchiolitis | 5 |
| Cystic Fibrosis | 4 |
| Hypersensitivity | 4 |
| Pneumonia | 4 |
| Pulmonary Eosinophilia | 4 |
| Disease | 3 |
| Dyspnea | 3 |
| Asthma, Occupational | 2 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.